Overview: What Iodine-131 Is and Why It Is Used in Cats
Iodine-131 (I-131) is a radioactive isotope of iodine used primarily to treat hyperthyroidism in cats. Hyperthyroidism is common in older cats and results from overactive thyroid glands that produce excess thyroid hormone. I-131 therapy destroys overactive thyroid tissue while sparing normal tissue, because thyroid cells concentrate iodine. Offered as an outpatient or short hospital stay, it is often favored for its high success rate and low risk of permanent complications when performed by experienced teams. This guide explains how it works, what to expect, and how to prepare.
How Iodine-131 Works in the Cat’s Body
Thyroid cells actively absorb iodine to make thyroid hormones. I-131 emits beta and gamma radiation; the beta particles destroy overactive thyroid cells, while gamma rays allow imaging and dose verification. Because iodine is trapped almost exclusively in thyroid tissue, most radiation exposure is localized. This targeted approach reduces damage to other organs and typically leads to normal thyroid function over weeks to months. The treatment is most effective when thyroid tissue takes up iodine; ectopic tissue or very large glands may respond less predictably.
Common Indications and Patient Selection
I-131 is indicated for cats with hyperthyroidism that is well-suited to this form of therapy. Ideal candidates are cats with non‑palpable or mildly palpable thyroid glands, no severe heart, kidney, or liver disease, and no significant malignant features such as suspected thyroid carcinoma with local invasion. Vets assess comorbidities, signalment, and prior treatments. Cats with advanced heart disease or severe kidney disease may need careful stabilization first; those with suspected thyroid carcinoma may need surgical evaluation before radioiodine. Age alone is not a barrier, but organ function and mobility (to limit radiation exposure to handlers) are considered.
Key Selection Criteria
- Diagnosed hyperthyroidism with elevated total T4 and clinical signs.
- No palpable firm or invasive thyroid nodules on exam or imaging.
- Stable cardiac, renal, and hepatic function as assessed by lab tests.
- No known hypersensitivity to iodine-based agents (rare in cats).
Dosing, Administration, and Facility Requirements
I-131 is administered as a single subcutaneous injection, typically at a hospital or referral center licensed to handle radioactive material. Dose is determined by a veterinary radiation specialist based on thyroid size, uptake, and comorbidities; common ranges in cats are approximately 2–10 millicuries (MBq). The cat remains in a designated radiation containment area until radiation levels fall below site-specific release thresholds, which can take days to weeks. Owners do not handle the cat during hospitalization and receive instructions on safe interaction after discharge.
Typical Dose and Hospitalization Parameters
| Parameter | Verified Detail | Source Type |
|---|---|---|
| administered activity | 2–10 mCi (74–370 MBq), weight- and uptake-based | Veterinary Nuclear Medicine Guidelines |
| hospitalization duration | 3–10 days or until radiation decay to site limits | Regulatory and facility protocols |
| isolation and handling rules | Minimize close contact; follow institutional release criteria | Facility Safety Protocols |
| success rate | >90% euthyroid at 6–12 months in uncomplicated cases | Published Clinical Studies |
Efficacy, Outcomes, and Long‑Term Management
Most cats become euthyroid within 6–12 weeks after I-131, with success rates often exceeding 90% for uncomplicated hyperthyroidism. Some cats may become hypothyroid and require lifelong levothyroxine; this is typically manageable with standard dosing and monitoring. Follow-up includes total T4 and sometimes free T4 and TSH at 1–2 months, then as needed until stable. Annual or biannual thyroid and kidney panels are recommended long-term because concurrent chronic kidney disease can emerge or become more apparent after treatment.
Safety, Radiation Precautions, and Side Effects
Side effects are usually mild and transient. Some cats experience nausea, temporary sore throat, or lethargy during the first few days. The major safety consideration is radiation protection for people; after discharge, owners are given instructions to limit close contact, avoid sharing a bed, and handle litter carefully for a short period. Facilities follow strict regulatory limits for release and provide written guidance. Hypothyroidism, if it occurs, is managed with oral thyroid hormone replacement and periodic monitoring of thyroid hormone levels.
Postdischarge Precautions (Examples)
- Minimize close sleeping contact for the time specified by the facility.
- Use gloves when changing litter for the period advised.
- Wash hands after handling the cat or its bedding.
- Pregnant people or those who are immunocompromised should consult their physician before close contact.
- Attend all follow-up labs to guide thyroid replacement if needed.
Alternatives and When I-131 Is Compared
Other treatments for feline hyperthyroidism include methimazole (oral or transdermal), surgical thyroidectomy, and dietary management. I-131 is often favored for its high cure rate and avoidance of long‑term medication, but it requires travel to a specialized facility and temporary isolation. Surgery provides rapid control but carries perioperative risks and may cause hypoparathyroidism; methimazole avoids radiation but requires consistent dosing and monitoring and may cause adverse effects. Dietary iodine restriction is an option in select cases and can be used alongside or after other therapies. Choosing the right approach depends on the cat’s health, owner preferences, and access to specialized care.
Cost, Logistics, and What to Expect Over Time
Total cost varies by region and facility but commonly ranges from 1,200 to 2,500 USD or more, covering the dose, hospitalization, baseline and follow‑up labs, and radiation safety measures. Payment plans or veterinary financing may be available. Logistics include arranging transport to a certified facility, planning for 3–10 days of hospitalization or nearby lodging, and scheduling follow‑up labs. Most cats return to normal thyroid function without complications, though hypothyroid cats usually do well on straightforward medication. Long‑term monitoring for kidney function and weight helps ensure quality of life after therapy.
Conclusion and Key Takeaways
I-131 is a highly effective, targeted treatment for hyperthyroidism in cats when performed at a licensed facility by experienced staff. It often leads to durable remission with a single treatment and avoids the need for daily medications, but it requires temporary isolation, careful follow‑up, and attention to radiation safety. Success depends on patient selection, accurate dosing, and ongoing monitoring for hypothyroidism or concurrent disease. By understanding the process, risks, and aftercare, owners can make informed decisions and support their cat’s long‑term health.